News by Tag: Fda


Penegra- recommended treatment for ED for senior people - Kamagrarx.co
March 14, 2013
Erectile dysfunction is a disorder that mainly affects the males & this has a great occurrence after 40 years of age in males.
Techniques of distributing drugs by Rablon - rablonhealthcare.com
March 13, 2013
The Rablon Healthcare Pvt Ltd this company has received the approval certificates of accomplished drug organizations like FDA, GDP, GMP, WHO & many more.
Contract manufacturing supported by Rablon - rablonhealthcare.com
March 13, 2013
Rablon healthcare Pvt Ltd this company made its presence in the pharmaceutical market in the year 2012 & from then has been employing effective techniques to mark a positive impression in the minds of the people.
Evolution of healthcare products in Mumbai - rablonhealthcare.com
March 13, 2013
The Rablon healthcare Pvt ltd this company is into the manufacturing & distribution of all essential healthcare products that are required by the people.
Availability of branded & generic drugs on kamagrarx.co
March 13, 2013
Branded & generic drugs are an important & necessary solution for the people to achieve treatment at the earliest.
Kamagrarx.co offers free shipping on purchases.
March 2, 2013
Kamagrarx.co has gained enough familiarity among all the people that has provided enough facilities for the humans & mainly has uplifted their lifestyle.
FDA gave green signal to Sanofi's Aubagio drug
October 4, 2012
After a series of failure to get many of its drugs get patent protection, Sanofi SA has finally tasted success. Its multiple sclerosis drug known as Aubagio has got green signal from the US regulators.
GlobalCompliancePanel to organize RAPS pre-approved webinar on "Good Documentation Practices for GMP Operations"
September 21, 2012
A RAPS pre-approved webinar on the topic, "Good Documentation Practices for GMP Operations" is being organized by GlobalCompliancePanel, a leading regulatory and compliance continuing education training provider, on November 13
Bridging the Gap: Co-Development of Targeted Therapeutics and Companion diagnostics in the US and EU
August 24, 2012
GlobalCompliancePanel,will conduct a RAPS pre-approved webinar on the topic,"Bridging the Gap: Co-Development of Targeted Therapeutics and Companion diagnostics in the US and EU" on September 18.
Seminar on Prepare and Submit 510(k) Premarket Notification Submissions for Success at Minneapolis
August 21, 2012
The speaker of this RAPS-approved seminar, which can earn participants up to 12 RAC points, will be David Dills, an independent Regulatory & Compliance Consultant.